202 related articles for article (PubMed ID: 26462774)
1. [NT5C2 expression in children with acute leukemia and its clinical significance].
Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
[TBL] [Abstract][Full Text] [Related]
2. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Aurora Family Genes in Acute Leukemia and Its Clinical Significance].
Liu ZL; Xing Y; Li T; Wang C; Liu SF; Zhao HY; Zhang RH; Ma YJ; Zhang XY; Tian WL; Liu L; Sun H; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):334-339. PubMed ID: 28446271
[TBL] [Abstract][Full Text] [Related]
4. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
5. [Expression of HOXB4, PRDM16 and HOXA9 in Patients with Acute Myeloid Leukemia and Its Clinical Significance].
Li L; Zhao CT; Cui BL; Wu SL; Liu XD; Su Z; Yang J; Wang W; Cui ZG; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):326-31. PubMed ID: 27150986
[TBL] [Abstract][Full Text] [Related]
6. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
[TBL] [Abstract][Full Text] [Related]
7. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
[TBL] [Abstract][Full Text] [Related]
8. [E-cadherin Expression in Children with Acute Leukemia and Its Clinical Significance].
Bao BX; An XZ; Li PF; Li YJ; Cui YH; Tang X; Liu QH; Hu YN; Liu W; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):339-347. PubMed ID: 30998135
[TBL] [Abstract][Full Text] [Related]
9. [Detecting HB-1 Expression Level in Bone Marrow of Acute Leukemia Patients by Real-Time Fluorescence Quantitative RT-PCR].
Wang QY; Li Y; Ji L; Liang ZY; Liu W; Ren HY; Qiu ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):8-15. PubMed ID: 29397811
[TBL] [Abstract][Full Text] [Related]
10. [Significance of quantification of WT1 mRNA for monitoring minimal residual disease in acute myeloid leukemia patients].
Qin YZ; Ruan GR; Li JL; Fu JY; Chang Y; Wang H; Li LD; Liu YR; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):649-52. PubMed ID: 16620548
[TBL] [Abstract][Full Text] [Related]
11. Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia.
Barz MJ; Hof J; Groeneveld-Krentz S; Loh JW; Szymansky A; Astrahantseff K; von Stackelberg A; Khiabanian H; Ferrando AA; Eckert C; Kirschner-Schwabe R
Blood; 2020 Mar; 135(12):921-933. PubMed ID: 31971569
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemia.
Qiao SK; Guo XN; Ren JH; Zhang JN; Wang Y
Exp Biol Med (Maywood); 2015 Jan; 240(1):128-34. PubMed ID: 25034723
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract][Full Text] [Related]
14. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
Jia XH; Zhu LP; Li JC; Wang CC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
[TBL] [Abstract][Full Text] [Related]
15. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.
Tzoneva G; Perez-Garcia A; Carpenter Z; Khiabanian H; Tosello V; Allegretta M; Paietta E; Racevskis J; Rowe JM; Tallman MS; Paganin M; Basso G; Hof J; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando A
Nat Med; 2013 Mar; 19(3):368-71. PubMed ID: 23377281
[TBL] [Abstract][Full Text] [Related]
16. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
17. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
18. CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia.
Rhein P; Mitlohner R; Basso G; Gaipa G; Dworzak MN; Kirschner-Schwabe R; Hagemeier C; Stanulla M; Schrappe M; Ludwig WD; Karawajew L; Ratei R
Blood; 2010 May; 115(18):3763-71. PubMed ID: 20228269
[TBL] [Abstract][Full Text] [Related]
19. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
20. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
